Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on September 9, 2025
MedBetterHealth and Working Nurses Home Care Partner to Deliver the CMS Innovation Center GUIDE Dementia Model
DAVIE, FL, UNITED STATES, September 9, 2025 /EINPresswire.com/ -- MedBetterHealth.org, a CMS-approved participant in the GUIDE Model (Guiding an Improved Dementia Experience), has formally selected Working Nurses Home Care as a strategic partner in …
OptraSCAN® to Introduce HER2 Scan + Analyze Pilot at CAP 2025
The HER2 Scan + Analyze Quantitative Solution Pilot gives labs early pay-per-slide access, increasing throughput, consistency, and scalable workflows. ORLANDO, FL, UNITED STATES, September 9, 2025 /EINPresswire.com/ -- OptraSCAN®, a leader in digital …
The Top Hospital Communications Software Vendors According to the FeaturedCustomers Fall 2025 Customer Success Report
FeaturedCustomers releases the Fall 2025 Hospital Communications Software Customer Success Report. COOPER CITY, FL, UNITED STATES, September 9, 2025 /EINPresswire.com/ -- Today FeaturedCustomers published the Fall 2025 Hospital Communications Software …
COPILOT Welcomes Bill Nolan as Chief Executive Officer
COPILOT Welcomes Healthcare Growth Leader with Proven Expertise in Market Access, Patient Services, and Pharma Commercialization MAITLAND, FL, UNITED STATES, September 9, 2025 /EINPresswire.com/ -- COPILOT, a leader in transforming patient access and …
Mellow Fellow today shared its product information and testing framework
Mellow Fellow outlined plans to streamline consumer access to product details and third-party lab testing information. FORT LAUDERDALE, FL, UNITED STATES, September 9, 2025 /EINPresswire.com/ -- Mellow Fellow today shared its product information and …
Telix Doses First Patient in Phase 3 BiPASS Trial: PSMA-PET Imaging for Prostate Cancer Diagnosis
MELBOURNE, Australia and INDIANAPOLIS, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces it has dosed the first patient in a Phase 3 clinical trial aimed at expanding the indications for …
LGSOC Awareness Day: Breakthrough FDA Approval Marks Hope for 80,000 Women
LGSOC Awareness Day 2025: A breakthrough FDA approval proves rare cancers deserve focus, funding, and a future of hope. MIAMI, FL, UNITED STATES, September 9, 2025 /EINPresswire.com/ -- September 9 marks the second annual Low-Grade Serous Ovarian Cancer …
Significant Breakthrough! eefit Far Infrared Technology Improves Two Major Symptoms of Alzheimer’s Disease, Bringing New Hope to Brain Health Protection
Hong Kong, Sept. 09, 2025 (GLOBE NEWSWIRE) -- With Hong Kong’s aging population, Alzheimer’s disease has become a major public health challenge. The Hong Kong Council of Social Service projects that by 2036, the number of people with dementia in Hong Kong …
University Hospital Foundation announces project to support Alberta dementia patients and their families
Edmonton, AB, Sept. 09, 2025 (GLOBE NEWSWIRE) -- The University Hospital Foundation is proud to launch the Dementia Care Pathways Project, a bold initiative aimed at transforming how we diagnose and support Albertans living with dementia in our communities …
Actuate Therapeutics Announces Proposed Public Offering of Common Stock
CHICAGO and FORT WORTH, Texas, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of high-impact, difficult …
Iridex Corporation Receives Formal Notification of Nasdaq Listing Compliance
MOUNTAIN VIEW, Calif., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal …
OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising
Strategic Partnership Combines OptimizeRx's Patented Micro-Neighborhood® Targeting Data with Lamar’s Vast Nationwide OOH Network to Strengthen OOH Media for Healthcare Marketing WALTHAM, Mass., Sept. 09, 2025 (GLOBE NEWSWIRE) -- OptimizeRx (the “Company”) …
InnovAge Announces Financial Results for the Fourth Quarter and Fiscal Year Ended June 30, 2025
DENVER, Sept. 09, 2025 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All- …
Picard Medical, Inc. Announces Exercise of Underwriters’ Over-Allotment Option in Connection with its Initial Public Offering
TUCSON, Ariz., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), today announced that the underwriters of its previously announced initial public offering of common stock, par value $0.0001 per share …
Celcuity Announces Upsized Senior Secured Term Loan Facility of $500 Million with Innovatus Capital Partners and Oxford Finance
MINNEAPOLIS, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (“Celcuity”), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it has entered into an amendment to its existing senior secured …
CRISPR Therapeutics to Present Late-Breaking Data at the American Heart Association (AHA) Scientific Sessions 2025
ZUG, Switzerland and BOSTON, Sept. 09, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that a late-breaking oral …
Serina Therapeutics Secures Up to $20 Million to Advance Registrational Trial of SER-252 in Parkinson’s Disease
Transaction structured to provide flexible funding to support Phase 1b registrational clinical study program in advanced Parkinson’s under the 505(b)(2) NDA pathway Evaluating complementary funding including strategic equity and non-dilutive alternatives …
Tevogen Estimates 5-Year Top-Line Revenue of ∼$6.5 Billion For Product Focused on Liver Cancer Prevention with High-Risk Chronic Hepatitis B Infection
Risk adjusted Net Present Value (rNPV) for TVGN 116 is estimated to exceed ~$325 million in the US alone. WARREN, N.J., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today shared asset value and …
OSE Immunotherapeutics Board Urges Support for Value-Driving Strategy and Open-Minded Governance - Publication of Circular for Combined Annual General Meeting of September 30, 2025
OSE Immunotherapeutics Board Urges Support for Value-Driving Strategy and Open-Minded Governance Publication of Circular for Combined Annual General Meeting of September 30, 2025 Nantes, September 9, 2025, 8:30 p.m. CET - OSE Immunotherapeutics SA (ISIN: …